Reuters logo
BRIEF-CVS Caremark CFO sees Q1 net revenue down 2.5-4 percent due to growth in generic drugs
December 13, 2012 / 1:50 PM / in 5 years

BRIEF-CVS Caremark CFO sees Q1 net revenue down 2.5-4 percent due to growth in generic drugs

CHICAGO, Dec 13 (Reuters) - CVS Caremark Corp : * CFO sees Q1 net revenue down 2.5-4 percent due to growth in generic drugs * CFO sees Q1 adjusted EPS $0.77-$0.80 * Thomson Reuters I/B/E/S Q1 earnings per share view $0.74 * Thomson Reuters I/B/E/S Q1 revenue view $31.98 billion * Sees Q1 same-store sales down 2-3.5 percent

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below